ARCHIVES

Study: Vismodegib Effective Where Surgery is Inappropriate

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008

NCI-Approved Clinical Trials

September 28, 2001

Vince DeVita: Startup Funds For New Clinical Research Difficult To Get; Many Private Physicians More Capable Of Caring For Cancer Patients Than Those In Centers

July 16, 1976